Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated to v3.5.4, indicating a newer document version and replacing the prior v3.5.3 tag.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:40.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s software/display footer revision was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T06:02:13.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:45.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:16.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision notes updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:32.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the site. The prior 3.4.1 notice about government funding and operating status was removed, indicating an update to the page template.
    Difference
    0.4%
    Check dated 2026-02-11T14:13:40.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.